258 related articles for article (PubMed ID: 34140931)
1. Is a Two-Year Growth Response to Growth Hormone Treatment a Better Predictor of Poor Adult Height Outcome Than a First-Year Growth Response in Prepubertal Children With Growth Hormone Deficiency?
Straetemans S; Rooman R; De Schepper J
Front Endocrinol (Lausanne); 2021; 12():678094. PubMed ID: 34140931
[TBL] [Abstract][Full Text] [Related]
2. Criteria for First-Year Growth Response to Growth Hormone Treatment in Prepubertal Children With Growth Hormone Deficiency: Do They Predict Poor Adult Height Outcome?
Straetemans S; De Schepper J; Thomas M; Tenoutasse S; Beauloye V; Rooman R
Front Endocrinol (Lausanne); 2019; 10():792. PubMed ID: 31849835
[No Abstract] [Full Text] [Related]
3. The response to growth hormone treatment in prepubertal children with growth hormone deficiency in Japan: Comparing three consecutive years of treatment data of The Foundation for Growth Science in Japan between the 1990s and 2000s.
Isojima T; Hasegawa T; Yokoya S; Tanaka T
Endocr J; 2017 Sep; 64(9):851-858. PubMed ID: 28679975
[TBL] [Abstract][Full Text] [Related]
4. The association between growth response to growth hormone and baseline body composition of children with growth hormone deficiency.
Esen I; Demirel F; Tepe D; Kara O; Koc N
Growth Horm IGF Res; 2013 Oct; 23(5):196-9. PubMed ID: 23890535
[TBL] [Abstract][Full Text] [Related]
5. Circulating IGF-I, IGFBP-3 and the IGF-I/IGFBP-3 Molar Ratio Concentration and Height Outcome in Prepubertal Short Children on rhGH Treatment over Two Years of Therapy.
Ballerini MG; Braslavsky D; Scaglia PA; Keselman A; Rodríguez ME; Martínez A; Freire AV; Domené HM; Jasper HG; Bergadá I; Ropelato MG
Horm Res Paediatr; 2017; 88(5):354-363. PubMed ID: 28926833
[TBL] [Abstract][Full Text] [Related]
6. Response to growth hormone treatment in isolated growth hormone deficiency versus multiple pituitary hormone deficiency.
Darendeliler F; Lindberg A; Wilton P
Horm Res Paediatr; 2011; 76 Suppl 1():42-6. PubMed ID: 21778748
[TBL] [Abstract][Full Text] [Related]
7. Growth hormone (GH) dosing during catch-up growth guided by individual responsiveness decreases growth response variability in prepubertal children with GH deficiency or idiopathic short stature.
Kriström B; Aronson AS; Dahlgren J; Gustafsson J; Halldin M; Ivarsson SA; Nilsson NO; Svensson J; Tuvemo T; Albertsson-Wikland K
J Clin Endocrinol Metab; 2009 Feb; 94(2):483-90. PubMed ID: 19001519
[TBL] [Abstract][Full Text] [Related]
8. Age at growth hormone therapy start and first-year responsiveness to growth hormone are major determinants of height outcome in idiopathic short stature.
Ranke MB; Lindberg A; Price DA; Darendeliler F; Albertsson-Wikland K; Wilton P; Reiter EO;
Horm Res; 2007; 68(2):53-62. PubMed ID: 17228181
[TBL] [Abstract][Full Text] [Related]
9. Observed and predicted growth responses in prepubertal children with growth disorders: guidance of growth hormone treatment by empirical variables.
Ranke MB; Lindberg A;
J Clin Endocrinol Metab; 2010 Mar; 95(3):1229-37. PubMed ID: 20097713
[TBL] [Abstract][Full Text] [Related]
10. Final height in idiopathic growth hormone deficiency: the KIGS experience. KIGS International Board.
Cutfield W; Lindberg A; Albertsson Wikland K; Chatelain P; Ranke MB; Wilton P
Acta Paediatr Suppl; 1999 Feb; 88(428):72-5. PubMed ID: 10102057
[TBL] [Abstract][Full Text] [Related]
11. Responses to growth hormone (GH) therapy in short children with normal GH secretion and no bone age delay: an analysis of potential factors affecting their response to rhGH therapy. A controlled study.
Soliman AT; Elawwa A; Itani M; Jour C; De Sanctis V
Acta Biomed; 2019 Sep; 90(8-S):43-51. PubMed ID: 31544806
[TBL] [Abstract][Full Text] [Related]
12. Growth hormone treatment in prepubertal children with celiac disease and growth hormone deficiency.
Giovenale D; Meazza C; Cardinale GM; Farinelli E; Mastrangelo C; Messini B; Citro G; Del Vecchio M; Di Maio S; Possenti I; Bozzola M
J Pediatr Gastroenterol Nutr; 2007 Oct; 45(4):433-7. PubMed ID: 18030209
[TBL] [Abstract][Full Text] [Related]
13. Catch-up growth after childhood-onset substitution in primary hypothyroidism: is it a guide towards optimal growth hormone treatment in idiopathic growth hormone deficiency?
Ranke MB; Schwarze CP; Mohnike K; von Mühlendahl KE; Keller E; Willgerodt H; Kiess W
Horm Res; 1998; 50(5):264-70. PubMed ID: 9873194
[TBL] [Abstract][Full Text] [Related]
14. Growth Responses During 3 Years of Growth Hormone Treatment in Children and Adolescents With Growth Hormone Deficiency: Comparison Between Idiopathic, Organic and Isolated Growth Hormone Deficiency, and Multiple Pituitary Hormone Deficiency.
Lim HH; Kim YM; Lee GM; Yu J; Han HS; Yu J
J Korean Med Sci; 2022 Mar; 37(11):e90. PubMed ID: 35315601
[TBL] [Abstract][Full Text] [Related]
15. Near-Adult Height After Growth Hormone Treatment in Children Born Prematurely-Data From KIGS.
Boguszewski MCS; Carlsson M; Lindberg A; Dahlgren J; Aydin F; Camacho-Hübner C; Hokken-Koelega ACS
J Clin Endocrinol Metab; 2020 Jul; 105(7):. PubMed ID: 32479603
[TBL] [Abstract][Full Text] [Related]
16. Growth hormone (GH) dose-dependent IGF-I response relates to pubertal height gain.
Lundberg E; Kriström B; Jonsson B; Albertsson-Wikland K;
BMC Endocr Disord; 2015 Dec; 15():84. PubMed ID: 26682747
[TBL] [Abstract][Full Text] [Related]
17. Effect of growth hormone therapy and puberty on bone and body composition in children with idiopathic short stature and growth hormone deficiency.
Högler W; Briody J; Moore B; Lu PW; Cowell CT
Bone; 2005 Nov; 37(5):642-50. PubMed ID: 16139578
[TBL] [Abstract][Full Text] [Related]
18. Growth hormone therapy in children: predictive factors and short-term and long-term response criteria.
Pozzobon G; Partenope C; Mora S; Garbetta G; Weber G; Barera G
Endocrine; 2019 Dec; 66(3):614-621. PubMed ID: 31423546
[TBL] [Abstract][Full Text] [Related]
19. Increased response, but lower responsiveness, to growth hormone (GH) in very young children (aged 0-3 years) with idiopathic GH Deficiency: analysis of data from KIGS.
Ranke MB; Lindberg A; Albertsson-Wikland K; Wilton P; Price DA; Reiter EO
J Clin Endocrinol Metab; 2005 Apr; 90(4):1966-71. PubMed ID: 15634724
[TBL] [Abstract][Full Text] [Related]
20. Height at start, first-year growth response and cause of shortness at birth are major determinants of adult height outcomes of short children born small for gestational age and Silver-Russell syndrome treated with growth hormone: analysis of data from KIGS.
Ranke MB; Lindberg A;
Horm Res Paediatr; 2010; 74(4):259-266. PubMed ID: 20431273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
